Litigation Details for Seagen Inc. v. Daiichi Sankyo Co., Ltd. (E.D. Tex. 2020)
✉ Email this page to a colleague
Seagen Inc. v. Daiichi Sankyo Co., Ltd. (E.D. Tex. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-10-19 |
| Court | District Court, E.D. Texas | Date Terminated | 2022-07-19 |
| Cause | 35:271 Patent Infringement | Assigned To | James Rodney Gilstrap |
| Jury Demand | Both | Referred To | |
| Parties | SEAGEN INC. | ||
| Patents | 7,994,135 | ||
| Attorneys | Sean Kang | ||
| Firms | Gillam and Smith LLP | ||
| Link to Docket | External link to docket | ||
Details for Seagen Inc. v. Daiichi Sankyo Co., Ltd. (E.D. Tex. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-08-30 | 152 | Other Seagen Patents in Same Family US Patent No. 8,703,714 US Patent No. 7,994,135 … See, e.g., ’039 Patent, (22), (60); U.S. Patent Nos. 7,498,298, Claim 1, 7,994,135, Claim 1, 8,703,714… Pat. No. 7,994,135, which is a division of application No. 10/983,340…isolation from the rest of the patent” • Unlike Baxalta, the ’039 patent is entirely consistent with…past’ that the ’039 patent sought to address” • The patent actually states is that “there | External link to document | |
| 2021-09-14 | 155 | Memorandum & Opinion | related patents to the ʼ039 Patent (see Plaintiff’s Exhibits 27, 28 (U.S. Patent Nos. 7,994,135 and 8,…infringement of U.S. Patent No. 10,808,039 (“the ʼ039 Patent”). The ʼ039 Patent is entitled “Monomethylvaline…series of patent applications and patents that ultimately claims priority to a provisional patent application…and 2 of the ʼ039 Patent. Claim 1 is the sole independent claim in the ʼ039 Patent and is reproduced …It is a ‘bedrock principle’ of patent law that ‘the claims of a patent define the invention to which | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
